ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 35 filers reported holding ADICET BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $209,000 | -79.4% | 14,317 | -71.8% | 0.01% | -75.0% |
| Q1 2022 | $1,013,000 | -21.1% | 50,715 | -30.9% | 0.02% | -20.0% |
| Q4 2021 | $1,284,000 | +319.6% | 73,415 | +88.1% | 0.03% | +275.0% |
| Q3 2021 | $306,000 | +155.0% | 39,034 | +7.5% | 0.01% | +100.0% |
| Q2 2021 | $120,000 | -47.8% | 36,297 | -14.1% | 0.00% | -55.6% |
| Q1 2021 | $230,000 | -35.2% | 42,239 | +67.1% | 0.01% | -30.8% |
| Q4 2020 | $355,000 | +21.2% | 25,275 | +2.4% | 0.01% | -27.8% |
| Q3 2020 | $293,000 | – | 24,683 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |